Protocol No.: A051901
- Title
- Phase I Trial of Methotrexate, Rituximab, Lenalidomide, and Nivolumab (NIVO-MR2) Induction followed by Lenalidomide and Nivolumab Maintenance in Primary CNS Lymphoma
- Principal Investigator
- Aulakh, Sonikpreet
- Phase
- I
- Age Group
- Adult
- Participating Institution
- Mary Babb Randolph Cancer Center
- Contact
- Nina Moore, RN
- Research Specialist
- Phone: +1 304-293-2991
- Email: nina.moore@hsc.wvu.edu